Synageva BioPharma (GEVA) Announces $80M Common Offering

January 3, 2013 7:29 AM EST Send to a Friend
Synageva BioPharma Corp. (“Synageva”) (NASDAQ: GEVA), has commenced a $80 million underwritten public offering of shares of its common stock. In connection with this offering, Synageva expects to grant to the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. Morgan Stanley and J.P. Morgan are acting as joint book-running managers in the offering, and Cowen and Company is acting as co-manager in the offering.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Equity Offerings

Related Entities

JPMorgan, Morgan Stanley, Cowen & Co

Add Your Comment